MIRIALIS
Pharmaceuticals and biotechnology
In pharma and biotech every process is documented, validated and controlled. That means many hours spent writing, searching and checking documents, and long sales cycles where a lost contact costs a lot.
The commercial value sitting idle.
Where it sits
- Contacts from CPHI, ACHEMA and industry shows
- Requests for samples or data sheets with no follow-up
- Quotes and projects postponed by the customer
- Customers with only one product or service active
Postponed projects
A postponed project is not a lost project: coming back at the right time with a technical update reopens the conversation.
Technical content for each decision-maker
In pharma several roles decide: quality, production, purchasing. Each needs different content.
Customers active on one service
Whoever already knows you and has qualified you is the easiest contact for a second product.
Processes worth making faster.
Search across SOPs and documentation
Natural-language search citing the document and the reference version.
Deviations and CAPA
An assistant finds similar past deviations, proposes the investigation structure and a draft for review.
Batch record review
Automatic completeness and consistency checks that flag anomalies to the reviewer.
Documents for customers and audits
Drafts generated from approved documentation, always with final human review.
CPHIACHEMAPharmintech
Frequently asked questions
Are communications GDPR compliant?
Before writing to anyone we check the legal basis and consents; contacts who cannot be reached stay out. For the details we always work with your legal advisor.
How do you handle validation and GMP?
We design support tools with human review, traceability and version control, and agree with your quality team a risk-based validation approach.